Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218471 · ClinicalTrials.gov registry record · NA
Cannabis Reduction and Functional Outcomes
A NA study of Cannabis Use Disorder, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 1
- Study location
NCT07218471: Recruiting NA study of Cannabis Use Disorder, sponsored by Medical University of South Carolina.
NCT07218471 is a NA study of Cannabis Use Disorder that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 176 participants, above the 104-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218471, a NA study of Cannabis Use Disorder, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in urinary cannabinoids. The study aims to assess improvements in cannabis-related problems, sleep, cognitive performance, CUD severity, and quality of life.
Primary Outcome
Rutgers Marijuana Problem Index (RMPI)- higher scores associated with worse outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Contingency Management
- BEHAVIORAL CBT4CBT (Computerized Cognitive Behavioral Therapy)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2026-03-13 |
| Est. Completion | 2030-01-30 |
| Phase | NA |
What NCT07218471 shows while recruiting
NCT07218471 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, above the 104-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (69% higher).
The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Motivational Interviewing is the first listed.
NCT07218471 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT07218471 about?
NCT07218471 is a clinical study titled "Cannabis Reduction and Functional Outcomes". This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in uri...
What is the current status of trial NCT07218471?
This trial is currently recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2026-03-13. Estimated completion is 2030-01-30.
What conditions does trial NCT07218471 study?
This clinical trial studies the following conditions: Cannabis Use Disorder.
What interventions are being tested in trial NCT07218471?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Contingency Management (BEHAVIORAL), CBT4CBT (Computerized Cognitive Behavioral Therapy) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07218471?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07218471 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07218471's enrollment target sits among peer trials
176 8th of 34 higher than 27 of 34 other Cannabis Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
RECRUITING · NA
-
Determining the Effect of Six Weeks of Cannabis Abstinence on Fronto- Striatal fMRI Markers in Adolescents With Cannabis Use Disorder (ABSCAN)
RECRUITING · NA
-
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
RECRUITING · NA
-
A Brief Intervention for Cannabis Use
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI